Unheard of to have a trial with 19 participants show statistical signifigance easily beating .05 standard.....
Big pharma runs trials with 5000 patients to show an overall benefit of life extension for a month that has huge side effects. And they call that a great new drug...Pfff to the drugs that dont cure,have horendous side effects and effectivness decreases quickly.
- Forums
- ASX - By Stock
- Ann: FDA Grants Orphan Drug Designation for Revascor
Unheard of to have a trial with 19 participants show statistical...
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.03 |
Change
-0.040(3.76%) |
Mkt cap ! $1.181B |
Open | High | Low | Value | Volume |
$1.07 | $1.07 | $1.02 | $5.788M | 5.580M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 141560 | $1.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.03 | 126960 | 17 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 173357 | 1.015 |
25 | 239130 | 1.010 |
22 | 308331 | 1.005 |
45 | 1096603 | 1.000 |
3 | 41925 | 0.995 |
Price($) | Vol. | No. |
---|---|---|
1.020 | 4739 | 4 |
1.025 | 179989 | 19 |
1.030 | 86924 | 14 |
1.035 | 159644 | 17 |
1.040 | 133381 | 12 |
Last trade - 15.26pm 21/06/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online